1. Home
  2. GCTS vs XBIT Comparison

GCTS vs XBIT Comparison

Compare GCTS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCT Semiconductor Holding Inc.

GCTS

GCT Semiconductor Holding Inc.

N/A

Current Price

$2.13

Market Cap

190.4M

Sector

Finance

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.20

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GCTS
XBIT
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.4M
66.8M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
GCTS
XBIT
Price
$2.13
$2.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.2M
36.5K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $2,866,000.00
N/A
Revenue This Year
$772.99
N/A
Revenue Next Year
$152.91
$30.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.96
$2.09
52 Week High
$3.93
$3.44

Technical Indicators

Market Signals
Indicator
GCTS
XBIT
Relative Strength Index (RSI) 54.09 47.52
Support Level $1.70 $2.16
Resistance Level $2.69 $2.48
Average True Range (ATR) 0.11 0.04
MACD 0.02 0.01
Stochastic Oscillator 65.94 66.67

Price Performance

Historical Comparison
GCTS
XBIT

About GCTS GCT Semiconductor Holding Inc.

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness. Geographically, operates in South Korea and the United States, with maximum revenue from the USA.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: